Medicus Pharma (NASDAQ:MDCX – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Price Performance
NASDAQ MDCX opened at $3.13 on Friday. The company has a 50 day simple moving average of $3.21. Medicus Pharma has a 1-year low of $1.80 and a 1-year high of $6.00.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the stock. Brookline Capital Management upgraded shares of Medicus Pharma to a “strong-buy” rating in a report on Monday, December 23rd. Maxim Group started coverage on Medicus Pharma in a research report on Tuesday, December 17th. They set a “buy” rating and a $10.00 price target on the stock.
About Medicus Pharma
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Further Reading
- Five stocks we like better than Medicus Pharma
- What does consumer price index measure?
- MarketBeat Week in Review – 03/24 – 03/28
- What is a Bond Market Holiday? How to Invest and Trade
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Golden Cross Stocks: Pattern, Examples and Charts
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
